Renin/angiotensin/aldosterone system in malignant hypertension

Free article

Editorial

M Naruse et al. Intern Med. 1997 Oct.

Free article

. 1997 Oct;36(10):669-71.

doi: 10.2169/internalmedicine.36.669.

No abstract available

Comment on

Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Oka K, Hayashi K, Nakazato T, Suzawa T, Fujiwara K, Saruta T. Oka K, et al. Intern Med. 1997 Oct;36(10):700-4. doi: 10.2169/internalmedicine.36.700. Intern Med. 1997. PMID: 9372330

The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
van den Born BJ, Koopmans RP, van Montfrans GA. van den Born BJ, et al. Am J Hypertens. 2007 Aug;20(8):900-6. doi: 10.1016/j.amjhyper.2007.02.018. Am J Hypertens. 2007. PMID: 17679041
[Natriuretic hormone and blood pressure in patients with arterial hypertension].
Tomashets EA, Mazur NA, Masenko VP. Tomashets EA, et al. Kardiologiia. 1992 Jan;32(1):60-3. Kardiologiia. 1992. PMID: 1535395 Russian.
Three cases of malignant hypertension: the roles of endothelin-1 and the renin-angiotensin-aldosterone system.
Yoshida M, Nonoguchi H, Owada A, Ishiyama S, Maeda Y, Ando K, Iwamoto H, Shiigai T, Marumo F, Tomita K. Yoshida M, et al. Clin Nephrol. 1994 Nov;42(5):295-9. Clin Nephrol. 1994. PMID: 7851030
Malignant hypertension - the role of the paracrine renin-angiotensin system.
Fleming S. Fleming S. J Pathol. 2000 Oct;192(2):135-9. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH674>3.0.CO;2-Q. J Pathol. 2000. PMID: 11004688 Review.
[Malignant hypertension].
Tamura K, Sakai M, Tanaka Y, Tsurumi Y, Umemura S. Tamura K, et al. Nihon Rinsho. 2005 Mar;63 Suppl 3:137-42. Nihon Rinsho. 2005. PMID: 15813058 Review. Japanese. No abstract available.